Skip to main content
Year archive

HYUNDAI BIOSCIENCE CO., LTD. — 2022 filings

All 34 regulatory filings released by HYUNDAI BIOSCIENCE CO., LTD. (048410) in 2022, sourced directly from the official regulator.

34 Filings
2022 Period
2022 filings (34)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2022-12-16 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-14 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양도결정)
M&A Activity
2022-08-29 Korean
합병등종료보고서(자산양수도)
M&A Activity
2022-08-29 Korean
주요사항보고서(타법인주식및출자증권양도결정)
M&A Activity
2022-08-25 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-08-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-08-19 Korean
[기재정정]사업보고서 (2021.12)
Annual Report FY 2021
2022-08-16 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-08-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-08-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-08-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-07-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-07-15 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-07-01 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-04-01 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-04-01 Korean
정기주주총회결과(제22기)
Declaration of Voting Results & Voting Rights Announcements
2022-03-29 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2022-03-29 Korean
전환청구권행사
Share Issue/Capital Change
2022-03-22 Korean
[기재정정]감사보고서제출(2020사업연도)
Audit Report / Information FY 2020
2022-03-21 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2022-03-21 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-21 Korean
사업보고서 (2021.12)
Annual Report FY 2021
2022-03-21 Korean
투자판단관련주요경영사항(COVID-19 치료제 CP-COV03의 2상 임상시험계획 승인)
Legal Proceedings Report
2022-03-16 Korean
투자판단관련주요경영사항(COVID-19 치료제 CP-COV03의 2상 임상시험계획 신청서 제출(신청내용 일부변경))
Legal Proceedings Report
2022-03-15 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2022-03-14 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2022-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-02-24 Korean
투자판단관련주요경영사항(코로나-19 치료제 CP-COV03의 국내 제1상 임상시험 결과)
Legal Proceedings Report
2022-02-09 Korean
투자판단관련주요경영사항(COVID-19 치료제 CP-COV03의 제2상 임상시험계획 신청서 제출)
Legal Proceedings Report
2022-01-21 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-01-11 Korean